Biophytis SA, a clinical-stage biotechnology company focused on the development of therapeutics that are aimed at slowing the degenerative processes associated with aging and improving functional outcomes for patients suffering from age-related diseases, including severe respiratory failure in patients suffering from COVID-19, will hold its combined Annual General Meeting on April 26th 2021 at 5.00 p.m. CET at Sorbonne Université, 4 Place Jussieu, 75005 Paris.
March 10, 2021
· 4 min read
